SK Discovery Establishes Bio Strategy and Investment Division... Appoints Kim Jeong-hoon as Head

Jung-Hoon Kim, Head of Bio Strategy Investment at SK Discovery.
[Photo by SK Chemicals]

[Asia Economy Reporter Lee Gwan-joo] SK Discovery announced on the 6th that it has established the Bio Strategy and Investment Headquarters under the Bio Committee and appointed Kim Jung-hoon, head of the SK Chemicals Research and Development Center, as the head of the headquarters.

The newly established Bio Strategy and Investment Headquarters was created to support the establishment of a master plan for bio growth strategy, collaboration among related companies, and horizontal expansion, as the need to explore new business opportunities for bio affiliates under SK Discovery has emerged.

Led by Head Kim, the Bio Strategy and Investment Headquarters will have investment and R&D personnel from each affiliate such as SK Chemicals and SK Plasma jointly establish future growth strategies. Based on each affiliate's growth strategy, they will conduct biotech, venture capital (VC) investments, joint reviews of investment targets, and joint research on future technologies, expecting to create synergy among affiliates.

Head Kim is a pharmaceutical bio expert who graduated from Seoul National University College of Pharmacy and has worked at SK Chemicals since 1998. Based on 25 years of experience and expertise leading overseas business, marketing, development, and research organizations at SK Chemicals, he has been entrusted with the important role of simultaneously promoting the growth and synergy of bio affiliates under SK Discovery.

Head Kim said, "Bio affiliates under SK Discovery each have growth engines through excellent talent and business portfolios," adding, "I will play a sufficient role to help each affiliate grow further and create synergy."

This content was produced with the assistance of AI translation services.